Werngard Czechtizky

Werngard Czechtizky is an experienced Executive Director and Head of Medicinal Chemistry at AstraZeneca, overseeing a team of 95 FTEs and managing portfolio and resource allocation within the department. Czechtizky plays a key role in the AZ global chemistry leadership team and is involved in setting the company's chemistry strategy, focusing on innovation in Medicinal, Computational, and Analytical Chemistry. Prior to AstraZeneca, Czechtizky held leadership roles at Sanofi and Aventis, managing large teams and participating in external collaborations. With a strong academic background, including a PhD in bioorganic chemistry from ETH Zürich and ongoing Executive MBA studies at Imperial College Business School, Czechtizky has a robust scientific and managerial profile.